those with a diagnosis of asthma only and no diagnosis of asthma or COPD had significantly less previous use of a controller medication after FDA alerts compared with before FDA alerts (p <0.005).

Explore strategies for controlling COPD and improving health, with a focus on management and lifestyle changes.

This includes steroid-containing combinations and long-acting ... other COPD treatments, such as inhaled steroid-containing combination therapies," said Vasant Narasimhan, Global Head Drug ...

Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...

Certain Medicare plans typically cover at least part of the cost of inhalers for COPD. There are also several ways to further save on costs.

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

Purpose: The utilization of controller medications before initiating a long-acting β 2-adrenergic ... with a diagnosis of asthma, 37% with COPD, 65% with COPD and asthma, and 21% of patients ...

Medicare Part D and Medicare Advantage (Part C) plans with drug coverage ... inhalers for COPD. Some are short acting and intended for use when symptoms occur, while others are long acting and ...